Timing of nephrologist referral and arteriovenous access use: The CHOICE Study

作者: Brad C. Astor , Joseph A. Eustace , Neil R. Powe , Michael J. Klag , John H. Sadler

DOI: 10.1053/AJKD.2001.26833

关键词: CatheterInternal medicineMedicineSurgeryKidney diseaseReferralDialysis catheterHemodialysisDialysisCohortNephrology

摘要: c Recent clinical practice guidelines recommend the creation of an arteriovenous (AV) vascular access (ie, native fistula or synthetic graft) before start chronic hemodialysis therapy to prevent need for complicationprone dialysis catheters. We report on association referral a nephrologist with duration dialysis-catheter use and type used in first 6 months therapy. The study population is representative cohort 356 patients questionnaire, laboratory, medical record data collected as part Choices Healthy Outcomes Caring End-Stage Renal Disease Center Study. Patients who reported being seen by at least 1 month starting (75%) were more likely than those referred later AV initiation (39% versus 10%; P < 0.001) after (74% 56%; 0.01). within initiating catheter median 202 days compared 64, 67, 19 4, 4 12, greater 12 therapy, respectively (P trend 0.001). fistula, rather graft, their (45% 31%;P These associations remained adjustment age, sex, race, marital status, education, insurance coverage, comorbid disease albumin level, body mass index, underlying renal diagnosis. show that late substantially increases likelihood associated prolonged use. Regardless time referral, only minority treatment, 25% had not initiation. Thus, further efforts improve both patterns preparation are needed. © 2001 National Kidney Foundation, Inc.

参考文章(18)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
S J Schwab, P Y Fan, Vascular access: concepts for the 1990s. Journal of The American Society of Nephrology. ,vol. 3, pp. 1- 11 ,(1992) , 10.1681/ASN.V311
B Hoen, M Kessler, A Paul-Dauphin, D Hestin, EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. Journal of The American Society of Nephrology. ,vol. 9, pp. 869- 876 ,(1998) , 10.1681/ASN.V95869
Catherine O. Stehman-Breen, Donald J. Sherrard, Daniel Gillen, Michael Caps, Determinants of type and timing of initial permanent hemodialysis vascular access Kidney International. ,vol. 57, pp. 639- 645 ,(2000) , 10.1046/J.1523-1755.2000.00885.X
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Jean-Louis Vanherweghem, Patricia Cabolet, Michel Dhaene, Michel Goldman, Jean-Claude Stolear, Jean-Pierre Sabot, Yves Waterlot, Martine Marchal, Complications related to subclavian catheters for hemodialysis. Report and review. American Journal of Nephrology. ,vol. 6, pp. 339- 345 ,(1986) , 10.1159/000167187
Sheldon Greenfield, Lisa Sullivan, Rebecca A. Silliman, Kimberly Dukes, Sherrie H. Kaplan, Principles and Practice of Case Mix Adjustment: Applications to End-Stage Renal Disease American Journal of Kidney Diseases. ,vol. 24, pp. 298- 307 ,(1994) , 10.1016/S0272-6386(12)80195-8
Neil R. Powe, Michael J. Klag, John H. Sadler, Gerard F. Anderson, Eric B. Bass, William A. Briggs, Nancy E. Fink, Andrew S. Levey, Nathan W. Levin, Klemens B. Meyer, Haya R. Rubin, Albert W. Wu, Choices for Healthy Outcomes In Caring for End Stage Renal Disease Seminars in Dialysis. ,vol. 9, pp. 9- 11 ,(2007) , 10.1111/J.1525-139X.1996.TB00890.X
Neil R. Powe, Bernard Jaar, Susan L. Furth, Judith Hermann, William Briggs, Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney International. ,vol. 55, pp. 1081- 1090 ,(1999) , 10.1046/J.1523-1755.1999.0550031081.X